相关实验视频
Updated: May 28, 2025
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.3K
[新型致病性治疗肌痛性骨髓灰质炎]
T M Alekseeva1, P S Isabekova1, E I Kondratova1
1Almazov National Medical Research Centre, St. Petersburg, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|February 11, 2025
概括
肌痛性骨髓灰质炎的治疗方法正在发展,超越了传统疗法. 新的向免疫疗法为患有这种自身免疫神经肌肉疾病的患者提供更快的症状缓解和更少的副作用.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性神经肌肉结合障碍,导致显著的肌肉衰弱和疲劳.
- 目前的治疗方法,如抗胆酶剂和广泛的免疫抑制剂都有局限性,包括副作用和不一致的缓解率.
- 耐火性MG病例需要开发更安全,更有效的治疗策略.
研究的目的:
- 审查已批准的,并开发针对性免疫疗法用于肌痛性骨髓灰质炎.
- 突出针对性治疗对 MG 管理的传统免疫抑制疗法的优势.
主要方法:
- 关于肌痛性骨髓灰质炎 (myasthenia gravis) 发病和治疗的科学文献的综述.
- 对已批准和正在研究的向免疫疗法的分析,包括单克隆抗体和融合蛋白.
- 针对性治疗与传统治疗的疗效,安全性和缓解诱导的比较.
主要成果:
- 向免疫疗法提供了MG病原性途径的特定阻断.
- 经批准的药物如eculizumab和ravulizumab表现出快速作用和长期缓解的潜力.
- 与传统的免疫抑制剂相比,这些新型疗法通常具有更有利的副作用概况.
结论:
- 向免疫疗法在治疗严重骨髓灰质炎方面取得了重大进展,特别是在耐药病例中.
- 这些疗法提供了一个有前途的替代方案,提高了疗效和安全性.
- 针对性药物如eculizumab和ravulizumab在俄罗斯的可用性扩大了MG患者的治疗选择.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
01:15Myasthenia Gravis: Diagnostic Tests
602
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
602
01:31Skeletal Muscle Relaxants: Therapeutic Uses
462
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
462
01:28Disorders of the Skeletal Muscle
858
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
858
01:28Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
608
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
608